Navigating Complex Refractory CMV Cases in SOT Recipients: Expert Approaches
Webinar/Online
Monday, August 4, 2025 at 1:00pm PT - 2:00pm PT
Add this event to your calendar
Info
Topic
Explore approaches to optimizing antiviral treatment of refractory CMV in SOT recipients.
Credits Offered
This event offers
1.0 contact hour
to attendees.
Accreditation Info:
ANCC.
Additional Information
Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with cytomegalovirus.
Target Audience
This activity is intended for physicians, nurses, and clinical pharmacists, including transplant, infectious diseases, nephrology, and internal medicine specialists who care for SOT recipients with CMV infections.
Learning Objectives
Upon completion of this event, participants should be able to:
- Employ best practices for timely identification of refractory CMV infections following solid organ transplantation
- Appropriately modify antiviral therapy in solid organ transplant recipients with treatment refractory CMV infections
- Design antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy
Speakers
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Mass General Brigham Endowed Cancer Chair IV
Massachusetts General Hospital
Associate Professor, Harvard Medical School
Boston, Massachusetts